ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Opposes Line Item for Centers

May 23, 1980

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

February 6, 1976

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

New Subcontracts Planned In Bioassay Program Run by Traco-JITCO

May 23, 1975

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

February 3, 2012